A preliminary study on the occurrence of pharmaceutically active compounds in hospital wastewater and surface water in Hanoi, Vietnam

Clean - Soil, Air, Water

Volumn 42, Issue 3, 2014, Pages 267-275

  Tran, Ngoc Han ^a,b   Urase, Taro ^c   Ta, Thi Thao ^d  

^a Tokyo Institute of Technology ^*  (Japan)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c TOKYO UNIVERSITY OF TECHNOLOGY   (Japan)

^d VIETNAM NATIONAL UNIVERSITY   (Viet Nam)

Author keywords

Hospital wastewater; Pharmaceutically active compounds; Surface water; Vietnam; Water pollution

Indexed keywords

DRUG; EFFLUENT; RISK ASSESSMENT; SURFACE WATER; WASTE FACILITY; WASTE TREATMENT; WASTEWATER; WATER POLLUTION; WATER QUALITY; WATER TREATMENT;

HANOI; VIET NAM;

EID: 84896775138     PISSN: 18630650     EISSN: 18630669     Source Type: Journal    
DOI: 10.1002/clen.201300021     Document Type: Article

References (52)

1. C. G. Daughton, T. A. Ternes, Pharmaceuticals and Personal Care Products in the Environment: Agents of Subtle Change?, Environ. Health Perspect. 1999, 107 (S6), 907-937.
2. O. A. Jones, N. Voulvoulis, J. N. Lester, Potential Ecological and Human Health Risks Associated with the Presence of Pharmaceutically Active Compounds in the Aquatic Environment, Crit. Rev. Toxicol. 2004, 34 (4), 335-350.
3. L. H. M. L. Santos, A. N. Araújo, A. Fachini, A. Pena, C. Delerue-Matos, M. C. B. S. Montenegro, Ecotoxicological Aspects Related to the Presence of Pharmaceuticals in the Aquatic Environment, J. Hazard. Mater. 2010, 175 (1-3), 45-95.
4. F. A. Caliman, M. Gavrilescu, Pharmaceuticals, Personal Care Products and Endocrine Disrupting Agents in the Environment - a Review, Clean - Soil Air Water 2009, 37 (4-5), 277-303.
5. T. Heberer, Occurrence, Fate, and Removal of Pharmaceutical Residues in the Aquatic Environment: A Review of Recent Research Data, Toxicol. Lett. 2002, 131 (1-2), 5-17.
6. B. Halling-Sørensen, S. Nors Nielsen, P. F. Lanzky, F. Ingerslev, H. C. Holten Lützhøft, S. E. Jørgensen, Occurrence, Fate and Effects of Pharmaceutical Substances in the Environment - a Review, Chemosphere 1998, 36 (2), 357-393.
7. S. D. Kim, J. Cho, I. S. Kim, B. J. Vanderford, S. A. Snyder, Occurrence and Removal of Pharmaceuticals and Endocrine Disruptors in South Korean Surface, Drinking, and Waste Waters, Water Res. 2007, 41 (5), 1013-1021.
8. T. Okuda, N. Yamashita, H. Tanaka, H. Matsukawa, K. Tanabe, Development of Extraction Method of Pharmaceuticals and Their Occurrences Found in Japanese Wastewater Treatment Plants, Environ. Int. 2009, 35 (5), 815-820.
9. C. Wu, A. L. Spongberg, J. D. Witter, M. Fang, A. Ames, K. P. Czajkowski, Detection of Pharmaceuticals and Personal Care Products in Agricultural Soils Receiving Biosolids Application, Clean - Soil Air Water 2010, 38 (3), 230-237.
10. D. W. Kolpin, E. T. Furlong, M. T. Meyer, E. M. Thurman, S. D. Zaugg, L. B. Barber, H. T. Buxton, Pharmaceuticals, Hormones, and Other Organic Wastewater Contaminants in U.S. Streams, 1999-2000: A National Reconnaissance, Environ. Sci. Technol. 2002, 36 (6), 1202-1211.
11. C. Tixier, H. P. Singer, S. Oellers, S. R. Muller, Occurrence and Fate of Carbamazepine, Clofibric Acid, Diclofenac, Ibuprofen, Ketoprofen, and Naproxen in Surface Waters, Environ. Sci. Technol. 2003, 37 (6), 1061-1068.
12. A. F. Martins, C. A. Mallmann, D. R. Arsand, F. M. Mayer, C. G. B. Brenner, Occurrence of the Antimicrobials Sulfamethoxazole and Trimethoprim in Hospital Effluent and Study of Their Degradation Products after Electrocoagulation, Clean - Soil Air Water 2011, 39 (1), 21-27.
13. P. H. Roberts, K. V. Thomas, The Occurrence of Selected Pharmaceuticals in Wastewater Effluent and Surface Waters of the Lower Tyne Catchment, Sci. Total Environ. 2006, 356 (1-3), 143-153.
14. T. A. Ternes, Analytical Methods for the Determination of Pharmaceuticals in Aqueous Environmental Samples, Trends Anal. Chem. 2001, 20 (8), 419-434.
15. M. Gros, M. Petrovic, D. Barcelo, Multi-Residue Analytical Methods Using LC-Tandem MS for the Determination of Pharmaceuticals in Environmental and Wastewater Samples: A Review, Anal. Bioanal. Chem. 2006, 386 (4), 941-952.
16. S. Managaki, A. Murata, H. Takada, B. C. Tuyen, N. H. Chiem, Distribution of Macrolides, Sulfonamides, and Trimethoprim in Tropical Waters: Ubiquitous Occurrence of Veterinary Antibiotics in the Mekong Delta, Environ. Sci. Technol. 2007, 41 (23), 8004-8010.
17. H. A. Duong, N. H. Pham, H. T. Nguyen, T. T. Hoang, H. V. Pham, V. C. Pham, M. Berg, et al., Occurrence, Fate and Antibiotic Resistance of Fluoroquinolone Antibacterials in Hospital Wastewaters in Hanoi, Vietnam, Chemosphere 2008, 72 (6), 968-973.
18. H. A. Nguyen, Wastewater Management and Treatment in Urban Areas in Vietnam, in Proceedings of 1st International Workshop on Water Environment Partnership in Asia (WEPA), 2010, pp. 211-215.
19. N. H. Tran, T. Urase, O. Kusakabe, The Characteristics of Enriched Nitrifier Culture in the Degradation of Selected Pharmaceutically Active Compounds, J. Hazard. Mater. 2009, 171 (1-3), 1051-1057.
20. T. Urase, T. Kikuta, Separate Estimation of Adsorption and Degradation of Pharmaceutical Substances and Estrogens in the Activated Sludge Process, Water Res. 2005, 39 (7), 1289-1300.
21. K. Kishida, N. Furusawa, Application of Shielded Column Liquid Chromatography for Determination of Sulfamonomethoxine, Sulfadimethoxine, and Their N-4-Acetyl Metabolites in Milk, J. Chromatogr. A 2004, 1028 (1), 175-177.
22. A. Y. Lin, Y. T. Tsai, Occurrence of Pharmaceuticals in Taiwan's Surface Waters: Impact of Waste Streams from Hospitals and Pharmaceutical Production Facilities, Sci. Total Environ. 2009, 407 (12), 3793-3802.
23. K. V. Thomas, C. Dye, M. Schlabach, K. H. Langford, Source to Sink Tracking of Selected Human Pharmaceuticals from Two Oslo City Hospitals and a Wastewater Treatment Works, J. Environ. Monit. 2007, 9 (12), 1410-1418.
24. T. Heberer, K. Reddersen, A. Mechlinski, From Municipal Sewage to Drinking Water: Fate and Removal of Pharmaceutical Residues in the Aquatic Environment in Urban Areas, Water Sci. Technol. 2002, 46 (3), 81-88.
25. M. J. Gomez, M. Petrovic, A. R. Fernandez-Alba, D. Barcelo, Determination of Pharmaceuticals of Various Therapeutic Classes by Solid-Phase Extraction and Liquid Chromatography-Tandem Mass Spectrometry Analysis in Hospital Effluent Wastewaters, J. Chromatogr. A 2006, 1114 (2), 224-233.
26. C. Ort, M. G. Lawrence, J. Reungoat, G. Eaglesham, S. Carter, J. Keller, Determining the Fraction of Pharmaceutical Residues in Wastewater Originating from a Hospital, Water Res. 2010, 44 (2), 605-615.
27. R. Andreozzi, M. Raffaele, P. Nicklas, Pharmaceuticals in STP Effluents and Their Solar Photodegradation in Aquatic Environment, Chemosphere 2003, 50 (10), 1319-1330.
28. S. Zuehlke, U. Duennbier, T. Heberer, Determination of Polar Drug Residues in Sewage and Surface Water Applying Liquid Chromatography-Tandem Mass Spectrometry, Anal. Chem. 2004, 76 (22), 6548-6554.
29. A. Joss, S. Zabczynski, A. Göbel, B. Hoffmann, D. Löffler, C. S. McArdell, T. A. Ternes, et al., Biological Degradation of Pharmaceuticals in Municipal Wastewater Treatment: Proposing a Classification Scheme, Water Res. 2006, 40 (8), 1686-1696.
30. A. A. Alturki, N. Tadkaew, J. A. McDonald, S. J. Khan, W. E. Price, L. D. Nghiem, Combining MBR and NF/RO Membrane Filtration for the Removal of Trace Organics in Indirect Potable Water Reuse Applications, J. Membr. Sci. 2010, 365 (1-2), 206-215.
31. N. Tadkaew, M. Sivakumar, S. J. Khan, J. A. McDonald, L. D. Nghiem, Effect of Mixed Liquor pH on the Removal of Trace Organic Contaminants in a Membrane Bioreactor, Bioresour. Technol. 2010, 101 (5), 1494-1500.
32. V. L. Cunningham, C. Perino, V. J. D'Aco, A. Hartmann, R. Bechter, Human Health Risk Assessment of Carbamazepine in Surface Waters of North America and Europe, Regul. Toxicol. Pharm. 2010, 56 (3), 343-351.
33. N. Vieno, T. Tuhkanen, L. Kronberg, Elimination of Pharmaceuticals in Sewage Treatment Plants in Finland, Water Res. 2007, 41 (5), 1001-1012.
34. L. Lissemore, C. Hao, P. Yang, P. K. Sibley, S. Mabury, K. R. Solomon, An Exposure Assessment for Selected Pharmaceuticals within a Watershed in Southern Ontario, Chemosphere 2006, 64 (5), 717-729.
35. J. B. Quintana, T. Reemtsma, Sensitive Determination of Acidic Drugs and Triclosan in Surface and Wastewater by Ion-Pair Reverse-Phase Liquid Chromatography/Tandem Mass Spectrometry, Rapid Commun. Mass Spectrom. 2004, 18 (7), 765-774.
36. B. Kasprzyk-Hordern, R. M. Dinsdale, A. J. Guwy, The Occurrence of Pharmaceuticals, Personal Care Products, Endocrine Disruptors and Illicit Drugs in Surface Water in South Wales, UK, Water Res. 2008, 42 (13), 3498-3518.
37. M. Clara, B. Strenn, N. Kreuzinger, Carbamazepine as a Possible Anthropogenic Marker in the Aquatic Environment: Investigations on the Behaviour of Carbamazepine in Wastewater Treatment and during Groundwater Infiltration, Water Res. 2004, 38 (4), 947-954.
38. EC, Technical Guidance Document on Risk Assessment, (TGD). Part II, Technical Report, Institute for Health and Consumer Protection, European Chemicals Bureau, European Commission (EC), Luxembourg 2003.
39. M. Cleuvers, Aquatic Ecotoxicity of Pharmaceuticals Including the Assessment of Combination Effects, Toxicol. Lett. 2003, 142 (3), 185-194.
40. L. H. Heckmann, A. Callaghan, H. L. Hooper, R. Connon, T. H. Hutchinson, S. J. Maund, R. M. Sibly, Chronic Toxicity of Ibuprofen to Daphnia magna: Effects on Life History Traits and Population Dynamics, Toxicol. Lett. 2007, 172 (3), 137-145.
41. H. J. De Lange, W. Noordoven, A. J. Murk, M. Lurling, E. T. Peeters, Behavioural Responses of Gammarus pulex (Crustacea, Amphipoda) to Low Concentrations of Pharmaceuticals, Aquat. Toxicol. 2006, 78 (3), 209-216.
42. F. Pomati, A. G. Netting, D. Calamari, B. A. Neilan, Effects of Erythromycin, Tetracycline and Ibuprofen on the Growth of Synechocystis sp. and Lemna minor, Aquat. Toxicol. 2004, 67 (4), 387-396.
43. J.-W. Kim, H. Ishibashi, R. Yamauchi, N. Ichikawa, Y. Takao, M. Hirano, M. Koga, et al., Acute Toxicity of Pharmaceutical and Personal Care Products on Freshwater Crustacean (Thamnocephalus platyurus) and Fish (Oryzias latipes), J. Toxicol. Sci. 2009, 34 (2), 227-232.
44. M. Isidori, M. Lavorgna, A. Nardelli, A. Parrella, L. Previtera, M. Rubino, Ecotoxicity of Naproxen and Its Phototransformation Products, Sci. Total Environ. 2005, 348 (1-3), 93-101.
45. Y. Kim, K. Choi, J. Jung, S. Park, P. G. Kim, J. Park, Aquatic Toxicity of Acetaminophen, Carbamazepine, Cimetidine, Diltiazem and Six Major Sulfonamides, and Their Potential Ecological Risks in Korea, Environ. Int. 2007, 33 (3), 370-375.
46. K. P. Henschel, A. Wenzel, M. Diedrich, A. Fliedner, Environmental Hazard Assessment of Pharmaceuticals, Regul. Toxicol. Pharm. 1997, 25 (3), 220-225.
47. M. Cleuvers, Mixture Toxicity of the Anti-Inflammatory Drugs Diclofenac, Ibuprofen, Naproxen, and Acetylsalicylic Acid, Ecotoxicol. Environ. Saf. 2004, 59 (3), 309-315.
48. B. Ferrari, N. Paxéus, R. L. Giudice, A. Pollio, J. Garric, Ecotoxicological Impact of Pharmaceuticals Found in Treated Wastewaters: Study of Carbamazepine, Clofibric Acid, and Diclofenac, Ecotoxicol. Environ. Saf. 2003, 55 (3), 359-370.
49. R. Triebskorn, H. Casper, V. Scheil, J. Schwaiger, Ultrastructural Effects of Pharmaceuticals (Carbamazepine, Clofibric Acid, Metoprolol, Diclofenac) in Rainbow Trout (Oncorhynchus mykiss) and Common Carp (Cyprinus carpio), Anal. Bioanal. Chem. 2007, 387 (4), 1405-1416.
50. J. L. Zurita, G. Repetto, Á. Jos, M. Salguero, M. López-Artíguez, A. M. Cameán, Toxicological Effects of the Lipid Regulator Gemfibrozil in Four Aquatic Systems, Aquat. Toxicol. 2007, 81 (1), 106-115.
51. M. Isidori, A. Nardelli, L. Pascarella, M. Rubino, A. Parrella, Toxic and Genotoxic Impact of Fibrates and their Photoproducts on Non-Target Organisms, Environ. Int. 2007, 33 (5), 635-641.
52. C. Mimeault, A. J. Woodhouse, X. S. Miao, C. D. Metcalfe, T. W. Moon, V. L. Trudeau, The Human Lipid Regulator, Gemfibrozil Bioconcentrates and Reduces Testosterone in the Goldfish, Carassius auratus, Aquat. Toxicol. 2005, 73 (1), 44-54.